je.st
news
Actelion Rises After Winning Approval of Opsumit Lung Medicine
2013-10-21 11:15:34| Biotech - Topix.net
Actelion Ltd. rose the most in more than 17 months after winning U.S. approval for the lung drug Opsumit, giving the Swiss company a successor to a best-selling medicine that loses patent protection in late 2015.
Tags: medicine
approval
winning
lung
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|